Today's managed care market: examining the effectiveness of the "gatekeeper" mechanism
Article Abstract:
Point-of-service (POS) systems of care, where there is a stronger incentive for members to use network physicians, may be as effective or even more effective for managing moderately resource-intensive conditions than preferred provider organization (PPO) plans. This was gleaned from the results of a natural experiment in one region where the effect of the 'gatekeeper' mechanism could be examined. A patterns-of-treatment study involving a large employer whose members were enrolled in a PPO plan and a POS plan revealed that the overall charge per patient treatment episode was 29% lower in the POS system of care.
Publication Name: Compensation & Benefits Management
Subject: Insurance
ISSN: 0748-061X
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Evaluating health plan efficiency
Article Abstract:
First-generation claims data systems of the 1970s focused mostly on analyzing charge and utilization excesses for hospitalized patients. When costs of ambulatory services increased, employers saw the need to monitor both hospital and ambulatory experience to find out thefactors causing benefit cost increases. However, second-generation data analysis systems focusing on ambulatory utilization and charges also have theirshortcomings. Third-generation claims systems, which use 'per episode of care' as unit of analysis instead of 'per 1,000 individuals,' give more accurate assessments.
Publication Name: Compensation & Benefits Management
Subject: Insurance
ISSN: 0748-061X
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
Developing capitation rates for disease management programs
Article Abstract:
The pharmaceutical industry is using a new approach to market prescription drug products. Drug companies are introducing capitated disease management programs, particularly those designed to treat arthritis, asthma, diabetes, cancer and other chronic diseases. In developing these programs, pharmaceutical firms usually formulate and implement disease management guidelines, capitate all treatment services on a yearly basis, include their products in the program's formulary, and adopt a continuous quality improvement strategy.
Publication Name: Compensation & Benefits Management
Subject: Insurance
ISSN: 0748-061X
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Today's managed care market: benchmark results for medical care guidelines, part II. Today's managed care market: utilizing quantitative data to understand asthma treatment patterns
- Abstracts: Direct assignment and direct reimbursement: the cost-effective consumer directed dental plans
- Abstracts: Insurance company rating agencies: a description of their methods and procedures. Whole life dividend histories
- Abstracts: Systems reorganization: a winning strategy. What's the use? Empowering the user
- Abstracts: Survey shows actuaries taking on new roles. Whole life dividend survey